ThromboGenics Presenting Industry Expertise and Developments at Bio€quity Europe and Knowledge for Growth meetings in Ghent, Belgium

14 May 2018

ThromboGenics Presenting Industry Expertise and Developments at Bio€quity Europe and Knowledge for Growth meetings in Ghent, Belgium

Leuven, Belgium, ThromboGenics NV announces that it will be presenting at Bio€quity Europe taking place from 14-16 May, 2018 and at Knowledge for Growth, which takes place on 17 May, 2018. Both events are being held in Ghent, Belgium.

At Bio€quity Europe, CEO Patrik De Haes, MD will be providing an update on progress and outlook with regards to the Company’s strategy and its industry-leading diabetic eye disease development pipeline.

Separately, at the Knowledge for Growth meeting later in the week, CSO Jean Feyen, PhD, will present his insights on the industry development pipeline for diabetic eye disease. 

Details of the presentations are as follows:

Bio€quity Europe

Date:       Tuesday 15 May 2018
Time:       17:00 CEST
Location: Level 1+, Priorzaal, Het Pand, Ghent University

Knowledge for Growth

Date:       Thursday 17 May 2018
Time:       11:35 CEST
Location: Jan van Eyck Room (1st Floor), International Convention Center Ghent

Bio€quity Europe is a life science focused investor and partnering event organised by BioCentury, now celebrating its 19th annual meeting. It has showcased more than 700 leading European companies to thousands of investment and pharma business development professionals. 

Knowledge for Growth is a European life sciences conference organised by flanders.bio, providing insight into the global life sciences’ landscape, B2B Partnering, a trade fair with 100+ exhibitors and scientific poster presentations.